Coronavirus (Photo Credit: PTI)
Vancouver: 44% of Canadian adults have at least one long-term health problem such as heart disease, diabetes or mental illness. Eighty percent of these conditions can be prevented. However, long-term disease control and health promotion are not taken seriously enough. Instead, Canada’s healthcare system focuses on treating serious and long-term health conditions. As a result, our healthcare system will have to bear billions of dollars annually to treat chronic diseases and this will increase the burden on healthcare providers.
Although the corona virus epidemic has focused the world on preventing infectious diseases, many of the lessons learned from Covid-19 control can also be applied to long-term disease control. We – as scientists who work on health behavior change interventions and family physicians who are in favor of treatment control – have taken many epidemiological lessons that can be used to improve long-term disease control. Three issues are mentioned here. Read more: Coronavirus Update: Canadian Prime Minister Justin Tudor urges people to be vigilant in the growing case of coronavirus
The rate of Kovid-19 infection is not the same as in Canadians. The transition rate is higher in areas where low-income earners and blacks live. Similarly, health inequality means racists and locals, immigrants, people with disabilities and those at risk of poverty are at higher risk of long-term illness. No access to resources. Also, poverty, bitter experiences and inequality can affect the body, increasing the risk of long-term disease.
Health inequality has been known for a long time after the introduction of Covid-19. In response, we have seen community groups, public health organizations and the government work together to provide free masks, community screening sites, vaccines and other services for low-income and racist communities. Health inequalities that increase the risk of long-term disease can be eliminated by continuing to provide such services to the most vulnerable.
The same method doesn’t work for everyone:
Physical distance can reduce the risk of Covid-1 of, but it is impossible if you live in a multi-generation home, use public transportation or are disabled and rely on caregivers. Protected Covid-19 in different situations to reduce the risk of spreading a variety of safety measures, from masks to physical distance, physical barriers to even better when communities are involved and given the ability to develop appropriate advice and messages according to their own culture.
Similarly, long-term disease control programs need to be prepared keeping in mind the needs and priorities of the community. It is good to accept the participation of communities for which programs and policies have been developed. Community participation helps ensure that programs are tailored to the needs of the community members who will use them.
For example, researchers at the British Columbia Center for Chronic Disease Prevention and Management worked with about 300 members of the community to design physical distance programs, especially for people with disabilities. In six months, those involved with the program increased their weekly physical activity by 363 percent and made significant improvements in their heart and lung health. The program would not have been so successful if the community members had not helped to prepare the program according to the specific challenges and needs of persons with disabilities.
We can and should quickly bring research into practice:
The epidemic has proven that science laboratories can be used to accelerate innovation to communities and individual citizens. The epidemic has led many researchers to close their own projects and collaborate with the world to identify and detect the virus, study its spread and create a test vaccine. Funds were allocated to enhance research collaboration. These actions accelerated the pace of the research process. Topics have been transformed into quick guidelines for public health advice, medical care and vaccines, which have been distributed and used around the world.
The study could guide the realization of a proven long-term disease control program. However, work to translate health research evidence into practice is apparently slow. One study found that it took 17 years to bring any health research into practice. One of the main reasons for these delays is that scientists who develop or test long-term disease control programs and communities, healthcare and government agencies that provide these programs do not usually work together.
The epidemic has changed the culture of science. We have seen the benefits when scientists collaborate regularly and industry and government partnerships are ready to quickly bring new discoveries. If we work with long-term disease control with equal urgency, the speed of evidence-based things can be accelerated and these can be made available to communities across the country.
Applying the lessons learned from Covid-19 to long-term disease control has the potential to benefit millions of Canadians and save billions of dollars on healthcare costs. The anti-COVID-19 response has proven that focused and collaborative efforts can be effective outcomes in disease control and treatment.
(This is a monitored and automatically generated story from a syndicated news feed, most likely not modified or edited by the latest staff)